Last updated: January 30, 2023
Sponsor: Weill Medical College of Cornell University
Overall Status: Completed
Phase
N/A
Condition
N/ATreatment
N/AClinical Study ID
NCT04271748
19-11021081
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Subjects has active Crohn's disease of the ileum and/or colon. The diagnosis should beconfirmed by endoscopic or radiological evidence.
- Active inflammation on colonoscopy performed as evidenced by an SES-CD ≥ 6 (or ≥ 4 forisolated ileal disease) OR C-Reactive protein ≥ 1.0 mg/L OR fecal calprotectin ≥ 250 μg/g. Any or all of these results must be from within 180 days of study entrance.
- Subject should have BMI of >18.5 and <40
Exclusion
Exclusion Criteria:
- Subjects who decline to provide informed consent
- Subject with a history of an eating disorder, major gastrointestinal surgery withinthe past 3 months.
- Subject with a history of antibiotic use within 4 weeks.
- Subject with a history of bowel obstruction within the past 12 months
- Subject with a history of diabetes requiring medication
- Subject who is currently pregnant or breastfeeding will be excluded
- Subjects with current antibiotic use. In order to participate, subjects will berequired to have a 2-week wash-out period.
Study Design
Total Participants: 15
Study Start date:
January 14, 2021
Estimated Completion Date:
November 01, 2022
Connect with a study center
Weill Cornell Medicine
New York, New York 10065
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.